Brad Quick is a producer with the CNBC business news team.
Brad Quick is a producer with the CNBC business news team.
A gene therapy from Spark Therapeutics is offering patients with a rare genetic retinal disease that causes blindness some hope.
New medicines are increasingly targeting the genetic drivers of disease. But what if medicine could go further and correct the genetic defect itself?
Scientists are working on a new treatment for depression and PTSD: deep-brain stimulation.
When we think about taking medicines, we imagine popping a pill, or receiving a shot. But a new approach would leverage the body's electrical signals.
The Defense Department is helping to develop prosthetics that harness what we've learned about the brain's functions.
Imagine implanting electrodes in the hippocampus to help brain-injured patients process memories. That's what the Defense Department is attempting.
The impact of low oil prices and energy layoffs is reverberating across Louisiana — and being felt acutely in the bayou.
As oil prices have collapsed, drilling and overall business are down in Williston, a shale boomtown in North Dakota.
Spanish soccer star Gerard Piqué sits at the pinnacle of his sport, but that has not stopped him from looking for success in other areas.
Jamie Dimon, JPMorgan president & CEO, responds to the Goldman Sachs report suggesting JPMorgan would be worth more broken up.
Data also provided by 
